Accelerating Natural Health Innovation

Welcome to Shiru's health initiatives hub, dedicated to bettering the health of people and our planet through breakthrough natural ingredients.

Learn More
Scientists working at Shiru's Lab

About the GLP-1 Innovation Alliance

The GLP-1 Innovation Alliance represents a groundbreaking approach to natural health innovation.

By combining Shiru's proprietary AI-powered discovery platform with the collective expertise of industry leaders, we're accelerating the identification and development of natural ingredients that can effectively activate GLP-1 pathways.

This consortium brings together companies of all sizes, from Fortune 500 enterprises to emerging brands, in a collaboration that democratizes access to cutting-edge discovery capabilities.

Over the course of the first year, consortium members access exclusive findings, gain first opportunities to license breakthrough ingredients, and help shape research priorities.

Whether you're developing the next generation of functional foods, innovative beverages, or dietary supplements, the GLP-1 Innovation Alliance provides the scientific foundation and collaborative ecosystem to transform your product pipeline.

With flexible participation tiers designed to accommodate different company sizes and objectives, every member can meaningfully contribute to and benefit from this revolutionary approach to natural GLP-1 activation.

Timeline

August 2025

Application deadline

Submit by August 15th to secure a founding spot. Members gain priority access to discoveries, shape research priorities, and lead the charge in natural GLP-1 innovation from day one.

October 2025

Development kickoff

Consortium activities officially launch. Shiru begins ingredient discovery using its AI platform, and founding members receive the first round of insights, samples, and collaborative engagement.

Summer 2026

Next opportunity to join

Enrollment reopens in Summer 2026. Founding members will have already shaped early research, accessed exclusive findings, and positioned their brands at the forefront of the natural GLP-1 space.

Get Started Today

Frequently Asked Questions

What exactly is the GLP-1 Innovation Alliance?

It's an unprecedented collaboration where companies of all sizes work together with Shiru to explore natural approaches to GLP-1 pathway activation using our AI-powered discovery platform.

Who owns the intellectual property?

Dependent on the membership tier selected, consortium members receive “first right of negotiation” on molecule IP generated by Shiru for the defined performance attribute throughout the discovery period.

When will we see results?

Shiru is leading an iterative discovery process. Findings will be shared at least quarterly, with the first results expected within 2025.

Can we get samples?

Yes, sample access is included depending on the membership tier. Please fill out the form above to receive more information.

What if we're a competitor to another member?

The consortium is designed for pre-competitive collaboration. All members benefit from shared discoveries while maintaining their product development strategies. Engaging directly with other consortium members is not required.

Why should large companies collaborate with startups?

Diverse perspectives accelerate innovation. Startups bring agility and fresh thinking, while established companies provide resources and market expertise.

What are the different participation levels?

We offer three tiers—Discovery Leader, Innovation Partner, and Observer Member—each with different levels of access and influence. Pricing is scaled based on company size to ensure accessibility for all. Please fill out the form above to receive more information.

How long is the commitment?

Each member will be required to commit for 5 quarters (15 months), allowing sufficient time for meaningful discovery cycles and product development planning. All members are required to commit to the full 5 quarters.

What makes Shiru's approach unique?

Our AI platform can screen millions of natural compounds in silico, dramatically accelerating the discovery process compared to traditional methods. This technology, combined with collaborative industry input, creates unprecedented innovation velocity.

When does the consortium officially begin?

The GLP-1 Innovation Alliance launches in Q3 2025. Ground-floor participation ensures that your priorities align with and influence our initial research directions, providing your organization with access to our findings.

From discovery to Impact

See how Shiru’s cutting-edge technology accelerates ingredient innovation for a better future.

How Shiru works